Zomer E, Gurusamy K, Leach R, Trimmer C, Lobstein T, Morris S, et al
PT-141 (Bremelanotide) is a melanocortin receptor agonist peptide that works through the central nervous system to support sexual desire and arousal
GI side effects on restart
Supplemental Material Figures S1S5 Tables S1S8 Nonstandard Abbreviations and Acronyms ACE angiotensin-converting enzyme ASCVD atherosclerotic cardiovascular disease CAD coronary artery disease CKD chronic kidney disease CRP C-reactive protein CVOT cardiovascular outcomes trial GLP-1 RA glucagon-like peptide-1 receptor agonist HbA1c glycated hemoglobin HR hazard ratio LDL low-density lipoprotein MACE major adverse cardiovascular event SGLT2i sodium-glucose cotransporter-2 inhibitor SOUL Semaglutide Cardiovascular Outcomes Trial T2D type 2 diabetes This manuscript was sent to Jennifer Green, Guest Editor, for review by expert referees, editorial decision, and final disposition
After 48 h of incubation under regular culture conditions the cells were used for fluorescence microscopy measurements
Managing the side effects of GLP-1 (glucagon-like peptide-1) agonists requires a careful and systematic approach